Recently, using the B16F10 murine melanoma model, Kim and co-authors observed increased levels of LC3B and Nanog, a pluripotent stem cell gene, in these melanoma cells that had been previously shown to be resistant to the immune checkpoint blockade (ICB) therapy [68]. Here, MAP1LC3B is linked to melanoma.